WHO ICTRP trial
A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and…
EUCTR2010-018603-29-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-018603-29-IT |
|---|---|
| Public title | A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of FLUAD Surface Antigen, Inactivated, Adjuvanted with MF59C.1 Influenza Vaccine, Formulation 2010-2011, when Administered to Elderly Subjects - ND |
| Scientific title | A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of FLUAD Surface Antigen, Inactivated, Adjuvanted with MF59C.1 Influenza Vaccine, Formulation 2010-2011, when Administered to Elderly Subjects - ND |
| Primary sponsor | NOVARTIS VACCINES AND DIAGNOSTICS S.R.L. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | Influenza poses a significant threat to individual and public health, and influenza vaccination with a trivalent inactivated influenza vaccine is widely recommended to children, adults at risks and elderly. Due to antigenic changes of… |
| Interventions | Trade Name: FLUAD Pharmaceutical Form: Solution for injection INN or Proposed INN: Influenza, purified antigen Concentration unit: ml millilitre(s) Concentration type: equal Concentration number: .5- |
| Registration date | Aug 4, 2010 |
| Secondary IDs | V70_25S |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: